Skip to main content
Log in

Inhibition of interleukin-1 (IL-1) enhanced pain reflexes in the rabbit by CGP 28238

  • Papers Given at the 12th European Workshop on Inflammation, Halle, Germany, May 30–31, 1990
  • Free Communications
  • Published:
Agents and Actions Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. I. Wiesenberg-Boettcher, A. Schweizer, J. R. Green, K. Mueller, F. Maerki and J. Pfeilschifter,The pharmacological profile of CGP 28238, a novel highly potent anti-inflammatory compound. Drugs Expl. Clin. Res.XV, 501–510 (1989).

    Google Scholar 

  2. A. Schweizer and R. Brom,Differentiation of peripheral and central effects of analgesic drugs. Int. J. Tiss. React.VII, 79–83 (1985).

    Google Scholar 

  3. A. Schweizer, U. Feige, A. Fontana, K. Mueller and C. A. Dinarello,Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E 2 levels. Agents and Actions25, 246–251 (1988).

    Article  PubMed  Google Scholar 

  4. H. Juan,Mechanism of action of bradykinin-induced release of prostaglandin E. Naunyn-Schmiedeberg's Arch. Pharmacol.300, 77–85 (1977).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schweizer, A., Brom, R. & Wiesenberg-Boettcher, I. Inhibition of interleukin-1 (IL-1) enhanced pain reflexes in the rabbit by CGP 28238. Agents and Actions 32, 67–69 (1991). https://doi.org/10.1007/BF01983314

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01983314

Keywords

Navigation